Antisense as a neuroscience tool and therapeutic agent
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 24, 56-62
- https://doi.org/10.1016/s0166-2236(01)00010-8
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Antisense Oligonucleotides: Promise and RealityAnnual Review of Pharmacology and Toxicology, 2001
- Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivoNature Biotechnology, 2001
- Potent and nontoxic antisense oligonucleotides containing locked nucleic acidsProceedings of the National Academy of Sciences, 2000
- A cytosine analog that confers enhanced potency to antisense oligonucleotidesProceedings of the National Academy of Sciences, 1999
- Correlation of Toxicity and Pharmacokinetic Properties of a Phosphorothioate Oligonucleotide Designed to Inhibit ICAM-1Toxicologic Pathology, 1999
- Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNSMolecular Brain Research, 1998
- Use of Antisense Vectors and Oligodeoxynucleotides in Neuro-OncologyPediatric Neurosurgery, 1998
- Morpholino Antisense Oligomers: Design, Preparation, and PropertiesAntisense and Nucleic Acid Drug Development, 1997
- 2′-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial CellsJournal of Biological Chemistry, 1997
- 2'-O-alkyl oligoribonucleotides as antisense probes.Proceedings of the National Academy of Sciences, 1990